Mutagenicity of the oral carcinogen 4-nitroquinoline-1-oxide in cultured BigBlue™ rat tongue epithelial cells and fibroblasts

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 522, Issue 1-2, 2003, Pages 107-117

  Papp Szabó, Erzsebet ^a   Douglas, George R ^b   Coomber, Brenda L ^a   Josephy, P David ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

4 Nitroquinoline 1 oxide; cIIAssay; Oral carcinogenesis; Oral epithelial cells; Oral fibroblasts

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CARCINOGEN; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; DRUG CYTOTOXICITY; EPITHELIUM CELL; FIBROBLAST; GENOTOXICITY; MUTAGENESIS; MUTAGENICITY; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT; TONGUE; TRANSGENE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CELL LINE; EPITHELIUM; FIBROBLASTS; GLUTATHIONE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; TONGUE;

EID: 0037469392     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00285-3     Document Type: Article

References (50)

1. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg. Oral Med. Oral Pathol. 69:1990;325-330.
2. Smith C.J. Oral cancer and precancer: background. Br. Dent. J. 167:1989;377-383.
3. Davis S., Severson R.K. Increasing incidence of cancer of the tongue in the United States among young adults. Lancet. 2:1987;910-911.
4. Negri E., La Vecchia C., Levi F., Franceschi S., Serra-Majem L., Boyle P. Comparative descriptive epidemiology of oral and oesophageal cancers in Europe. Eur. J. Cancer Prev. 5:1996;267-279.
5. Johnson N. Tobacco use and oral cancer: a global perspective. J. Dent. Educ. 65:2001;328-339.
6. Cox S. Oral cancer in Australia - risk factors and disease distribution. Ann. R. Aust. Coll. Dent. Surg. 15:2000;261-263.
7. Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg R.S., Preston-Martin S., Bernstein L., Schoenberg J.B., Stemhagen A., Fraumeni J.F. Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48:1988;3282-3287.
8. Depue R.H. Rising mortality from cancer of the tongue in young white males. N. Engl. J. Med. 315:1986;647.
9. Llewellyn C.D., Johnson N.W., Warnakulasuriya K.A. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol. 37:2001;401-418.
10. Mathew I.E., Pandey M., Mathew A., Thomas G., Sebastian P., Krishnan N.M. Squamous cell carcinoma of the tongue among young Indian adults. Neoplasia. 3:2001;273-277.
11. Takagi M., Kayano T., Yamamoto H., Shibuya H., Hoshina M., Shioda S., Enomoto S. Causes of oral tongue cancer treatment failures. Analysis of autopsy cases. Cancer. 69:1992;1081-1087.
12. Garrote L.F., Herrero R., Reyes R.M., Vaccarella S., Anta J.L., Ferbeye L., Munoz N., Franceschi S. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br. J. Cancer. 85:2001;46-54.
13. Boffetta P., Ye W., Adami H.O., Mucci L.A., Nyren O. Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden. Br. J. Cancer. 85:2001;678-682.
14. Homann N., Tillonen J., Meurman J.H., Rintamaki H., Lindqvist C., Rautio M., Jousimies-Somer H., Salaspuro M. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 21:2000;663-668.
15. Binnie W.H., Rankin K.V., Mackenzie I.C. Etiology of oral squamous cell carcinoma. J. Oral Pathol. 12:1983;11-29.
16. Sugerman P.B., Shillitoe E.J. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis. 3:1997;130-147.
17. Ito N. In vivo carcinogenesis of 4-nitroquinoline 1-oxide and related compounds. Carcinog. Compr. Surv. 6:1981;117-153.
18. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis. 14:1993;1321-1325.
19. Eveson J.W. Animal models of intra-oral chemical carcinogenesis: a review. J. Oral Pathol. 10:1981;129-146.
20. Makita H., Tanaka T., Ohnishi M., Tamai Y., Torihara M., Yamahara J., Mori H., Satoh K., Hara A. Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases. Carcinogenesis. 16:1995;2171-2176.
21. Walker I.G., Sridhar R. The formation and repair of single-strand breaks in DNA of cultured mammalian cells treated with UV-light, methylating agents or 4-nitroquinoline-1-oxide. Chem. Biol. Interact. 12:1976;229-239.
22. von Pressentin M.M., El Bayoumy K., Guttenplan J.B. Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (MutaMouse) and the effects of 1, 4-phenylenebis(methylene)selenocyanate. Mutat. Res. 466:2000;71-78.
23. von Pressentin M.M., Kosinska W., Guttenplan J.B. Mutagenesis induced by oral carcinogens in lacZ mouse (MutaMouse) tongue and other oral tissues. Carcinogenesis. 20:1999;2167-2170.
24. Goth-Goldstein R., Tincknell B.P., Hughes M. Toxicity of 4-nitroquinoline 1-oxide in Chinese hamster ovary cells: influence of cell density and of position in the cell cycle. Mutat. Res. 140:1984;209-213.
25. Tsuda H. Role of DT diaphorase the cytotoxicity of menadione and 4-nitroquinoline-1-oxide in cultured mammalian fibroblastic cells. Cancer Lett. 55:1990;195-199.
26. Benson A.M. Conversion of 4-nitroquinoline 1-oxide (4NQO) to 4-hydroxyaminoquinoline 1-oxide by a dicumarol-resistant hepatic 4NQO nitroreductase in rats and mice. Biochem. Pharmacol. 46:1993;1217-1221.
27. Booth D.R. A relationship found between intra-oral sites of 4NQO reductase activity and chemical carcinogenesis. Cell Tissue Kinet. 23:1990;331-340.
28. Bailleul B., Daubersies P., Galiegue-Zouitina S., Loucheux-Lefebvre M.H. Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis. Jpn. J. Cancer Res. 80:1989;691-697.
29. Tada M. Seryl-tRNA synthetase and activation of the carcinogen 4-nitroquinoline 1-oxide. Nature. 255:1975;510-512.
30. Stanley J.S., Benson A.M. The conjugation of 4-nitroquinoline 1-oxide, a potent carcinogen, by mammalian glutathione transferases. 4-Nitroquinoline 1-oxide conjugation by human, rat and mouse liver cytosols, extrahepatic organs of mice and purified mouse glutathione transferase isoenzymes. Biochem. J. 256:1988;303-306.
31. Aceto A., Di Ilio C., Lo B.M., Bucciarelli T., Angelucci S., Federici G. Differential activity of human, rat, mouse and bacteria glutathione transferase isoenzymes towards 4-nitroquinoline 1-oxide. Carcinogenesis. 11:1990;2267-2269.
32. Fields W.R., Li Y., Townsend A.J. Protection by transfected glutathione S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis. 15:1994;1155-1160.
33. Yamamoto K., Inoue S., Kawanishi S. Site-specific DNA damage and 8-hydroxydeoxyguanosine formation by hydroxylamine and 4-hydroxyaminoquinoline 1-oxide in the presence of Cu(II): role of active oxygen species. Carcinogenesis. 14:1993;1397-1401.
34. Fann Y.C., Metosh-Dickey C.A., Winston G.W., Sygula A., Rao D.N., Kadiiska M.B., Mason R.P. Enzymatic and nonenzymatic production of free radicals from the carcinogens 4-nitroquinoline N-oxide and 4-hydroxylaminoquinoline N-oxide. Chem. Res. Toxicol. 12:1999;450-458.
35. Nunoshiba T., Demple B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res. 53:1993;3250-3252.
36. Ramotar D., Belanger E., Brodeur I., Masson J.Y., Drobetsky E.A. A yeast homologue of the human phosphotyrosyl phosphatase activator PTPA is implicated in protection against oxidative DNA damage induced by the model carcinogen 4-nitroquinoline 1-oxide. J. Biol. Chem. 273:1998;21489-21496.
37. McDiarmid H.M., Douglas G.R., Coomber B.L., Josephy P.D. Epithelial and fibroblast cell lines cultured from the transgenic BigBlue™ rat: an in vitro mutagenesis assay. Mutat. Res. 497:2001;39-47.
38. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
39. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356.
40. Tasevski V., Benn D., Peters G., Luttrell B., Simpson A. The Fischer rat thyroid cell line FRTL-5 exhibits a nondiploid karyotype. Thyroid. 8:1998;623-626.
41. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202:1988;343-361.
42. Coles B., Yang M., Lang N.P., Kadlubar F.F. Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo(a)pyrene-7,8-diol-9,10-oxide. Cancer Lett. 156:2000;167-175.
43. McDiarmid H.M., Douglas G.R., Coomber B.L., Josephy P.D. 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP)-induced mutagenesis in cultured BigBlue™ rat mammary epithelial and fibroblast cells. Environ. Mol. Mutagen. 39:2002;245-253.
44. Ryu J., Youn J., Kim Y., Kwon O., Song Y., Kim H., Cho K., Chang I. Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic BigBlue™ Rat2 cell line. Mutat. Res. 445:1999;127-135.
45. Banasiak D., Barnetson A.R., Odell R.A., Mameghan H., Russell P.J. Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line. Radiat. Oncol. Investig. 7:1999;77-85.
46. Kosower N.S., Kosower E.M. The glutathione status of cells. Int. Rev. Cytol. 54:1978;109-160.
47. Slivka A., Mytilineou C., Cohen G. Histochemical evaluation of glutathione in brain. Brain Res. 409:1987;275-284.
48. DeLeve L.D. Glutathione defense in non-parenchymal cells. Semin. Liver Dis. 18:1998;403-413.
49. Slavotinek A., McMillan T.J., Steel C.M. A comparison of micronucleus frequency and radiation survival in lymphoblastoid cell lines. Mutagenesis. 8:1993;569-575.
50. Takagi T., Sasai K., Shibamoto Y., Akagi K., Oya N., Shibata T., Kim J., Hiraoka M. The influence of DNA ploidy of a human tumor cell line on the frequencies of micronuclei or chromosome aberrations after irradiation. Mutat. Res. 418:1998;49-57.